Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.
about
Deletion and downregulation of MTAP contribute to the motility of esophageal squamous carcinoma cells.Genomic lesions drive the metastasis of esophageal squamous cell carcinoma.SLC52A3 expression is activated by NF-κB p65/Rel-B and serves as a prognostic biomarker in esophageal cancer.Co-activation of super-enhancer-driven CCAT1 by TP63 and SOX2 promotes squamous cancer progression
P2860
Genomic and Epigenomic Aberrations in Esophageal Squamous Cell Carcinoma and Implications for Patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Genomic and Epigenomic Aberrat ...... and Implications for Patients.
@en
type
label
Genomic and Epigenomic Aberrat ...... and Implications for Patients.
@en
prefLabel
Genomic and Epigenomic Aberrat ...... and Implications for Patients.
@en
P2860
P1433
P1476
Genomic and Epigenomic Aberrat ...... and Implications for Patients.
@en
P2093
H Phillip Koeffler
Ming-Rong Wang
P2860
P304
P356
10.1053/J.GASTRO.2017.06.066
P407
P50
P577
2017-07-27T00:00:00Z